Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.
第一作者:
Daniele,Raggi
第一单位:
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
作者:
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);无病生存(Disease-Free Survival);人类(Humans);男(雄)性(Male);肿瘤, 生殖细胞和胚胎性(Neoplasms, Germ Cell and Embryonal);预后(Prognosis);比例危险度模型(Proportional Hazards Models);研究设计(Research Design);腹膜后肿瘤(Retroperitoneal Neoplasms);回顾性研究(Retrospective Studies);青年人(Young Adult);甲胎蛋白类(alpha-Fetoproteins)
DOI
10.1016/j.urolonc.2015.04.008
PMID
25985712
发布时间
2015-06-13
- 浏览38

Urologic oncology
332.e19-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文